Insider Buying: Creo Medical Group PLC (LON:CREO) Insider Acquires 4,712 Shares of Stock

Creo Medical Group PLC (LON:CREO) insider Christopher Paul Hancock purchased 4,712 shares of the firm’s stock in a transaction on Monday, January 20th. The stock was bought at an average price of GBX 19 ($0.23) per share, for a total transaction of £895.28 ($1,103.92).

Creo Medical Group Stock Down 1.4 %

Shares of CREO stock opened at GBX 18.25 ($0.23) on Tuesday. The stock has a market cap of £66.02 million, a P/E ratio of -304.17 and a beta of 0.86. Creo Medical Group PLC has a 52 week low of GBX 12 ($0.15) and a 52 week high of GBX 43 ($0.53). The company has a quick ratio of 2.19, a current ratio of 3.24 and a debt-to-equity ratio of 29.96. The company’s fifty day simple moving average is GBX 17.54 and its two-hundred day simple moving average is GBX 23.61.

About Creo Medical Group

Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy.

The Company’s vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive.